+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Cartilage Degeneration Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Procedure Type; Application; and End User and Country - Regional Analysis and Market Forecasts by Procedure Type, Application and End User

  • ID: 5180779
  • Report
  • September 2020
  • Region: Asia Pacific
  • 117 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • CartiHeal, Inc
  • Smith & Nephew
  • Stryker Corporation
  • Vericel Corporation
  • MORE
The Asia Pacific cartilage degeneration market is expected to reach US$ 2,509.24 million by 2027 from US$ 1,721.26 million in 2019; it is estimated to grow at a CAGR of 5.0% from 2020 to 2027.

The cartilage degeneration market is growing primarily due to the increasing prevalence of sports injuries and obesity in Asia Pacific. However, the high cost of cartilage therapies is restraining the growth of the market. Additionally, growing number of product approvals and rising emphasis on regenerative medicines are likely to fuel the growth of the cartilage degeneration market during the forecast period.

Degeneration of cartilage can lead to pain and chronic inflammation in joints of the human body. Furthermore, damaged cartilage can potentially influence the quality of a patient’s life. Continuous research and developments are innovating new techniques and methodologies to deal with damages cartilages. A few of these techniques comprise joint replacement, cell therapies, and chondroplasty.

Companies operating in the cartilage degeneration market are undertaking various R& D activities to introduce more innovative products. For instance, in January 2019, Cellular Biomedicine Group, Inc, a biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, announced that its AlloJoin® therapy for Knee Osteoarthritis (KOA) has been approved as the first stem cell KOA drug application for a Phase II clinical trial in China.

The new cartilage therapies are adopt advanced cell technologies to strengthen the procedural outcomes. Furthermore, MEDIPOST announced that the Ministry of Food and Drug Safety (MFDS) has approved the Phase 3 clinical trial of CARTISTEM® for the treatment of patients with ankle joint osteochondral cartilage defects. Also, DePuySynthes Mitek Sports Medicine launched a new suite of knee arthroscopy solutions to improve operating room efficiency, simplify ACL and meniscus repair, and make these surgeries more reproducible.

The industry players in the cartilage degeneration market are focusing on establishing collaborations and partnerships for the development of advanced products with increasing procedural efficiency. For instance, Wright Medical Group announced the acquisition of Imascap SAS for US$ 88 million. Imascap SAS develops software for preoperative joint replacement surgery. The increasing number of product approvals, R& D, adoption of advanced technologies, and strategic activities are projected to offer lucrative growth opportunities for the cartilage degeneration market in APAC.

Countries in Asia Pacific are facing challenges due to increasing cases of COVID-19. Hospitals are already struggling to deal with rising pandemic pressure. To relieve healthcare systems, many clinics/hospitals are postponing non-critical surgeries. Despite China being a rapidly growing market for medical devices such as hip and knee implants, due to the COVID-19 crisis, hardly any elective surgeries were performed in the country in February. Considering the current healthcare scenario, medical device companies such as Stryker, CartiHeal Inc., and Smith & Nephew have predicated the decline in sales in China.

The knee segment accounted for the largest share of the market in 2019. The growth of this segment is attributed to the increasing prevalence of knee injuries. For instance, according to the study - based on NCBI data - published in an online newspaper, one in four adults suffers from chronic knee pain. Furthermore, increasing awareness of the benefits provided by cartilage repair is anticipated to drive the growth of the knee segment.

Major secondary sources associated with the Asia Pacific cartilage degeneration market report are World Health Organization (WHO), Indian Council of Medical Research (ICMR), National Center for Biotechnology Information (NCBI), Australian Institute of Health and Welfare, and others.

Reasons to Buy
  • Understand the Asia Pacific cartilage degeneration market landscape and identify segments that are most likely to guarantee a strong return.
  • Stay ahead of the race by comprehending the ever-changing competitive market landscape in the region.
  • Efficiently plan mergers and acquisitions, and partnership deals in the APAC cartilage degeneration market by identifying segments with the most promising probable sales.
  • Take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments.
  • Obtain revenue forecast for market based on various segments for the period 2019-2027
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • CartiHeal, Inc
  • Smith & Nephew
  • Stryker Corporation
  • Vericel Corporation
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Cartilage Degeneration Market - By Procedure Type
1.3.2 Asia Pacific Cartilage Degeneration Market - By Application
1.3.3 Asia Pacific Cartilage Degeneration Market- By End User
1.3.4 Asia Pacific Cartilage Degeneration Market - By Country

2. Asia Pacific Cartilage Degeneration Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Cartilage Degeneration Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cartilage Degeneration Market - Asia Pacific PEST Analysis
4.3 Expert Opinion

5. Asia Pacific Cartilage Degeneration Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Number of Sports Injuries
5.1.2 Increasing Prevalence of Obesity
5.2 Key Market Restraints
5.2.1 High Cost of Cartilage Repair Therapies
5.3 Key Market Opportunities
5.3.1 Growing Number of Product Approvals and Developments
5.4 Future Trends
5.4.1 Rising Emphasis on Regenerative Medicines
5.5 Impact analysis

6. Cartilage Degeneration Market - Asia Pacific Analysis
6.1 Asia Pacific Cartilage Degeneration Market Revenue Forecasts and Analysis

7. Asia Pacific Cartilage Degeneration Market Analysis and Forecasts To 2027 - By Procedure Type
7.1 Overview
7.2 Asia Pacific Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)
7.2.1 Asia Pacific Cartilage Degeneration Market Revenue and Forecasts to 2027, By Procedure Type (US$ Mn)
7.3 Osteochondral Transplant
7.3.1 Overview
7.3.2 Asia Pacific Osteochondral Transplant Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Chondroplasty
7.4.1 Overview
7.4.2 Asia Pacific Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Joint Replacement
7.5.1 Overview
7.5.2 Asia Pacific Joint Replacement Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Meniscus Transplants
7.6.1 Overview
7.6.2 Asia Pacific Meniscus Transplants Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Cell-based Cartilage Resurfacing
7.7.1 Overview
7.7.2 Asia Pacific Cell-based Cartilage Resurfacing Market Revenue and Forecast to 2027 (US$ Mn)
7.8 Other Procedures
7.8.1 Overview
7.8.2 Asia Pacific Other Procedures Market Revenue and Forecast to 2027 (US$ Mn)

8. Asia Pacific Cartilage Degeneration Market Analysis and Forecasts To 2027 - By Application
8.1 Overview
8.2 Asia Pacific Cartilage Degeneration Market, By Application 2019 & 2027 (%)
8.2.1 Asia Pacific Cartilage Degeneration Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Knee
8.3.1 Overview
8.3.2 Asia Pacific Knee Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hip
8.4.1 Overview
8.4.2 Asia Pacific Hip Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Other Applications
8.5.1 Overview
8.5.2 Asia Pacific Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)

9. Asia Pacific Cartilage Degeneration Market Analysis - By End-User
9.1 Overview
9.2 Asia Pacific Cartilage Degeneration Market, By End-User 2019-2027 (%)
9.2.1 Asia Pacific Cartilage Degeneration Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Hospitals and Specialty Centres
9.3.1 Overview
9.3.2 Asia Pacific Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Ambulatory Surgical Centres
9.4.1 Overview
9.4.2 Asia Pacific Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Asia Pacific Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

10. Cartilage Degeneration Market Revenue and Forecasts To 2027 - Geographical Analysis
10.1 Asia Pacific Cartilage Degeneration Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Asia Pacific: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Asia Pacific: Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.4 Asia Pacific: Cartilage Degeneration Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.5 Asia Pacific: Cartilage Degeneration Market, End User - Revenue and Forecast to 2027 (USD Million)
10.1.6 Asia Pacific: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
10.1.7 China: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 China: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 China: Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.3 China: Cartilage Degeneration Market, by Application- Revenue and Forecast to 2027 (USD Million)
10.1.7.4 China: Cartilage Degeneration Market, End User - Revenue and Forecast to 2027 (USD Million)
10.1.8 Japan: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Japan: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Japan: Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Japan: Cartilage Degeneration Market, by Application- Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Japan: Cartilage Degeneration Market, End User - Revenue and Forecast to 2027 (USD Million)
10.1.9 India: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 India: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 India: Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 India: Cartilage Degeneration Market, by Application- Revenue and Forecast to 2027 (USD Million)
10.1.9.4 India: Cartilage Degeneration Market, End User - Revenue and Forecast to 2027 (USD Million)
10.1.10 South Korea: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.10.1 South Korea: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.10.2 South Korea: Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.10.3 South Korea: Cartilage Degeneration Market, by Application- Revenue and Forecast to 2027 (USD Million)
10.1.10.4 South Korea: Cartilage Degeneration Market, End User - Revenue and Forecast to 2027 (USD Million)
10.1.11 Australia: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Australia: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Australia: Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Australia: Cartilage Degeneration Market, by Application- Revenue and Forecast to 2027 (USD Million)
10.1.11.4 Australia: Cartilage Degeneration Market, End User - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Asia Pacific Cartilage degeneration Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

12. Company Profiles
12.1 B. Braun Melsungen AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Smith & Nephew
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Stryker Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 CartiHeal, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Vericel Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
Note: Product cover images may vary from those shown
3 of 3
  • B. Braun Melsungen AG
  • Smith & Nephew
  • Stryker Corporation
  • CartiHeal, Inc
  • Vericel Corporation
Note: Product cover images may vary from those shown
Adroll
adroll